AMJ Podcast | Episode 1: Harnessing Imaging Biomarkers in Asthma: Lessons from VESTIGE - Part 1/2
The EMJ Podcast: Insights For Healthcare Professionals
Release Date: 05/09/2025
Infectious Disease Diagnostics: The New Era of STD Screening
The EMJ Podcast: Insights For Healthcare Professionals
In the third and final episode of our miniseries on infectious disease diagnostics, Jonathan sits down with global diagnostics leader Rosanna Peeling, Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine. Together, they explore the life-saving role of diagnostics in global health, from battling STDs to confronting COVID-19, and examine how equitable access, social innovation, and regulatory reform can transform disease control and pandemic preparedness. Timestamps: 00:00 – Introduction 06:09 – Rosanna’s interest in microbiology 08:12...
info_outline
Hema Now: Episode 18: Myeloma Genetics, CAR-T, and Emerging Immunotherapies
The EMJ Podcast: Insights For Healthcare Professionals
Rafael Fonseca is a distinguished Haematologist at Mayo Clinic, specialising in multiple myeloma and related plasma cell disorders. He earned his medical degree at Universidad Anáhuac in Mexico, and went on to complete his residency in Internal Medicine at the University of Miami, Florida, USA followed by a Hematology and Oncology fellowship at Mayo Clinic in Rochester, Minnesota, USA. Timestamps 01:44 – Quickfire questions 07:25 – CAR-T cell therapy 10:48 – Anti-CD38 antibodies 13:31 – Minimal residual disease 14:30...
info_outline
Breaking Barriers in Lung Cancer: Driving Change Through Early Screening
The EMJ Podcast: Insights For Healthcare Professionals
In this episode, Jonathan Sackier kicks off a special miniseries on lung cancer with Haval Balata, Consultant Respiratory Physician at Manchester University NHS Foundation Trust. From the Manchester Lung Health Check to robotic bronchoscopy, Balata shares insights into pioneering early detection efforts, the challenge of public misconceptions, and innovations reshaping lung cancer screening and diagnosis. Timestamps: 03:12 – Inspiration to specialise 04:09 – Early diagnosis barriers 08:02 – Manchester Lung Health Check 14:10 – Robot-assisted bronchoscopy 19:24 – Public misconceptions...
info_outline
Onc Now: Episode 18: What's New from ESGO 2025?
The EMJ Podcast: Insights For Healthcare Professionals
In this two-part series host Jonathan Sackier is joined by Bradley Monk, a pioneering figure in gynaecologic oncology. In Part 1, they discuss key updates from the European Society of Gynaecological Oncology (ESGO) Congress, including the updated ESGO-ESTRO-ESP endometrial cancer guidelines and the latest results from the KEYLYNK-001 study in ovarian cancer. With reflections from his three-decade career, Monk provides actionable takeaways for clinicians and researchers alike. Stay tuned for Part 2, where they delve into insights from SGO 2025. Timestamps: 00:00 - Quickfire...
info_outline
Bonus Episode: The clinician’s perspective on new intermittent catheterisation technology
The EMJ Podcast: Insights For Healthcare Professionals
In this bonus episode, join EMJ host Dr Hannah Moir as she speaks with our two urological experts, Dr Todd Linsenmeyer and Dr Chris Harding. They discuss recent advances in day-to-day technologies for intermittent catheterisation, covering innovations and advancements in catheter technology aimed at improving the user experience.
info_outline
Transforming Rheumatology Part 3: Testing Misconceptions and Future Vision
The EMJ Podcast: Insights For Healthcare Professionals
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice. Timestamps: 1:12 – A typical consultation 7:50 – Advice for clinicians
info_outline
Transforming Rheumatology Part 2: The Art of Connection and Building Patient Trust
The EMJ Podcast: Insights For Healthcare Professionals
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice. Timestamps: 0:14 – The power of hope for patients 1:08 – Opening her own practice
info_outline
Transforming Rheumatology Part 1: Blending Science and Soul
The EMJ Podcast: Insights For Healthcare Professionals
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice. Timestamp: 2:27 – The origins of ‘Hope Driven by Science’
info_outline
Hema Now: Episode 17: What Drives Change in Leukaemia Cells?
The EMJ Podcast: Insights For Healthcare Professionals
In this episode of Hema Now, host Jonathan Sackier is joined by Paolo Gallipoli, Clinical Reader at the Centre for Haemato-Oncology at Barts Cancer Institute, to break down the biology, onset, and treatment of myeloid leukaemias. They detail common misconceptions about myeloid leukaemias, explain the differences between chronic myeloid leukaemia and acute myeloid leukaemia, and discuss Gallipoli’s own research in the field, with a view towards future developments. Timestamps 01:34 – Quickfire questions 06:55 – Potential careers 08:43 – Common...
info_outline
Clinical Insights in Rheumatology 3/3: Hospital Mortality, JAK Inhibitors, and the Future of Rheumatology
The EMJ Podcast: Insights For Healthcare Professionals
In this three-part series, Jonathan Sackier sits down with Richard Conway, rheumatologist, researcher, and educator. Together, they delve into cutting-edge insights on polymyalgia rheumatica, immune ageing, and the future of rheumatology care. 01:47 – Interstitial Lung Disease 08:25 – Evolution of Rheumatology 11:39 – Wishes for Healthcare
info_outlineJoin us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the VESTIGE trial and their implications on asthma care.
Uncover:
· The importance of patient phenotyping: How can biomarkers and imaging improve asthma management?
· Mucus plugging and airflow obstruction: What does the latest research reveal?
· Biologics and airway remodeling: What did the VESTIGE trial reveal about biologics and airway remodeling?
· The role of imaging in clinical practice: How can CT scans provide new insights into asthma care?
Speakers
Mario Castro, University of Kansas School of Medicine, United States
Njira Lugogo, University of Michigan, Ann Arbor, Michigan, United States
Disclaimers:
· This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.
· The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program
· The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits
· See full US Prescribing Information for dupilumab
· MAT-US-2412937 v2.0 - Pro1 Expiration Date: 04/21/2026
Speaker disclosures:
· MC reports research support from the American Lung Association, AstraZeneca, Gala Therapeutics, Genentech, GSK, NIH, Novartis, PCORI, Pulmatrix, sanofi-aventis, Shionogi, and Theravance Biopharma, consultancy fees from Allakos, Amgen, Arrowhead Pharmaceuticals, Blueprint Medicines, Connect BioPharma, Genentech, GSK, Merck, Novartis, OM Pharma, Pfizer, Pioneering Medicines, sanofi-aventis, Teva, Third Rock Ventures, and Verona Pharmaceuticals, speaker fees from Amgen, AstraZeneca, Regeneron Pharmaceuticals Inc., and Sanofi, and royalties from Aer Therapeutics.
· NLL reports research support paid to institution from Amgen, AstraZeneca, Avillion, Genentech, Gossamer Bio, GSK, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, consultancy fees from and participation on advisory boards with Amgen, AstraZeneca, Genentech, GSK, Novartis, Regeneron Pharmaceuticals Inc., Sanofi, and Teva, travel support from AstraZeneca, and honoraria for non-speaker bureau presentations from AstraZeneca and GSK.
References:
1. Castro M et al. Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir Med. 2025;13:208-20. doi: 10.1016/S2213-2600(24)00362-X.